New Haven Pharmaceuticals is a company dedicated to the development of prescription drugs that utilize well-established drugs or GRAS (Generally Recognized as Safe) active pharmaceutical ingredients. By focusing on compounds with proven safety records, the company aims to create innovative, effective treatments that address unmet medical needs. Their approach reduces regulatory barriers and speeds up the time-to-market for new pharmaceutical solutions, ultimately ensuring that patients have access to safe and advanced medical therapies.
About us:
At New Haven Pharmaceuticals, we are committed to developing prescription pharmaceuticals that harness the power of GRAS (Generally Recognized as Safe) active pharmaceutical ingredients. Our mission is to create safe, innovative drug formulations that improve patient care and address unmet medical needs. By leveraging well-established compounds with proven safety records, we streamline the drug development process, ensuring rapid access to advanced treatments.
Our approach not only accelerates time-to-market but also maintains a strong focus on patient safety and efficacy, offering reliable solutions for a range of therapeutic areas. We aim to set new standards in the pharmaceutical industry with our innovative formulations and patient-centered care.
Meet our team
Dedicated professionals driving our success
Tony Fred
Chief Executive Officer
Founder and chief visionary, Tony Fred, leads New Haven Pharmaceuticals with a passion for innovation and growth. His hands-on approach drives the company’s strategic direction, from product development to marketing initiatives. Tony actively engages in shaping customer experience strategies, ensuring the company stays ahead in delivering high-quality, patient-focused pharmaceutical solutions. His leadership and dedication are the core of New Haven Pharma's success, pushing the company to continuously refine its offerings and meet the evolving needs of healthcare providers and patients alike.
Mich Stark
Chief Commercial Officer
Mich Stark thrives on challenges, bringing years of experience from his previous role as Commercial Director in the software industry. His strategic insights and innovative approach have been instrumental in driving the growth and success of New Haven Pharmaceuticals. Mich is recognized as one of the brightest minds in the industry, consistently contributing to the company's advancement in the commercial space. His expertise ensures that New Haven Pharma continues to deliver top-tier pharmaceutical solutions to its clients, while expanding its reach and impact in the healthcare sector.
Aline Turner
Chief Technical Officer
Aline Turner is a passionate leader who thrives on innovation and mentoring. As Chief Technical Officer at New Haven Pharmaceuticals, she oversees a team of over 100 in-house developers, guiding them in creating cutting-edge solutions for the pharmaceutical industry. Aline is dedicated to fostering a community of developers, sharing her expertise and driving technological advancements. Her leadership ensures that New Haven Pharma stays at the forefront of technical innovation, continually pushing boundaries to deliver high-quality pharmaceutical products and services.
Iris Joe
Chief Financial Officer
Iris Joe brings a wealth of international experience to her role as Chief Financial Officer at New Haven Pharmaceuticals. Her expertise helps the company navigate complex financial landscapes, making it easier to understand and optimize financial performance. Iris is committed to driving success and uses her professional acumen to elevate the company's financial strategies, ensuring sustainable growth. Her focus on delivering results pushes New Haven Pharma to reach new levels of excellence and profitability, supporting the company’s long-term goals and mission.